Tag: AI Drug Discovery
Chai Discovery scores BMS pact for AI-built antibodies
Chai Discovery adds Bristol Myers Squibb to its pharma roster for AI-built therapeutic antibodies.
Beyang banks $30M to push AI-designed eye and blood drugs
Chengdu-based Beyang Therapeutics closes an oversubscribed Series A to fund AI-designed retinal disease and leukemia candidates.
Aureka banks $100M Series B for biology foundation models
Aureka closes a $100M Series B to train biological foundation models for AI-driven drug discovery.
Pathos AI bets $125M on ADC its agent platform flagged
Pathos AI is paying $125M upfront for an Alphamab Oncology ADC that its Foundry agent platform flagged, plus a new…
Gates and Bezos back LifeMine’s $188M fungal drug revival
LifeMine is reviving its fungal genome platform with $188M from Bill Gates, Jeff Bezos and RA Capital, and will soon…
First AI-found brain target advances in Recursion-Roche pact
The first neuroscience target found through Recursion's $12B AI pact with Roche and Genentech is moving into an early discovery…
Novo Nordisk taps H1’s AI to speed trial design and site selection
Novo Nordisk partners with provider data company H1 to bring AI to trial design, enrollment and site selection.
GSK deepens AI drug discovery bet with $110M Relation expansion
GSK is paying AI biotech Relation up to $110M to generate human cell data and train foundation models for drug…